Latest News about MXCT
Recent news which mentions MXCT
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
September 28, 2022
From Benzinga
Obsessing over CPI? You could be missing bargain stocks that can build long-term returns, say these fund managers
August 10, 2022
From MarketWatch
Tickers
MXCT
From Motley Fool
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
MaxCyte Expects Q1 Sales To Beat Expectations, CFO Resigns
April 13, 2022
Tickers
MXCT
From Benzinga
From Benzinga
Earnings Scheduled For March 22, 2022
March 22, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
11 Health Care Stocks Moving In Monday's Intraday Session
January 24, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 23, 2021
From Benzinga
From MarketWatch
MaxCyte, Inc. (MXCT) Q3 2021 Earnings Call Transcript
November 12, 2021
Tickers
MXCT
From Motley Fool
91 Biggest Movers From Yesterday
November 12, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 01, 2021
From Benzinga
From InvestorPlace
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 08, 2021
From Benzinga
18 Stocks Moving in Friday's Pre-Market Session
October 08, 2021
From Benzinga
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
October 08, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 04, 2021
From Benzinga